Equine Sarcoid: From BPV-Driven Oncogenesis to Host-Sustained Tumor Persistence.

Overview

• This research article reviews the mechanisms behind equine sarcoid development, focusing on how bovine papillomaviruses (BPV) initiate tumor formation and how host biological processes sustain tumor persistence and progression.

Introduction to Equine Sarcoid

• Equine sarcoid is the most frequent skin tumor in horses and other equids.
• These tumors are associated with infection by bovine papillomaviruses, mainly BPV-1 and BPV-2.
• Despite viral infection being a key factor, it does not fully explain why these tumors differ widely in clinical presentation, their tendency to recur, or why they rarely regress spontaneously.
• This indicates that host factors beyond the virus contribute to tumor behavior.

Role of BPV in Oncogenesis

• BPV oncoproteins, especially the E5 protein, play a central role in transforming host cells (fibroblasts) into cancerous cells.
• E5 activates the platelet-derived growth factor beta receptor (PDGFβR), which triggers several signaling pathways:
• PI3K/AKT pathway – promotes cell survival and growth.
• MAPK pathway – involved in cell proliferation.
• p38 signaling – related to stress and inflammation responses.
• This activation results in increased fibroblast proliferation, survival, and evasion of the immune system by disrupting normal antigen presentation.

Host Factors in Tumor Persistence

• Though viral proteins initiate tumor formation, the persistence of sarcoids depends crucially on host processes.
• Key host-driven mechanisms include:
• Remodeling of the extracellular matrix (ECM) – changes in the structure surrounding cells support tumor growth.
• Activation of fibroblast and myofibroblast phenotypes – these cells contribute to tumor maintenance and stiffness.
• Chronic inflammation signaling – ongoing inflammation may promote tumor survival and growth.
• Ineffective immune clearance – the host immune response fails to eliminate the tumor cells effectively.

Molecular and Multi-Omic Insights

• Recent advances in transcriptomics and epigenomics have revealed additional layers of tumor regulation, such as:
• Long non-coding RNAs (lncRNAs) – these RNA molecules may regulate gene expression to maintain the cancerous state.
• DNA methylation alterations – epigenetic changes that modify gene expression without changing DNA sequence.
• Circulating microRNAs – small RNAs detectable in blood that can influence tumor biology and serve as potential biomarkers.
• Virus-host chimeric transcripts – fusion RNAs combining viral and host sequences, potentially stabilizing the tumor phenotype.
• These factors highlight a complex interplay between viral genes and host regulatory networks ensuring tumor survival.

Conceptual Framework and Implications

• The authors propose a model where viral oncogene expression initiates tumor formation, but persistent tumor growth is primarily maintained by host-driven molecular and cellular remodeling.
• This dual viral-host mechanism explains clinical features like lesion persistence, frequent recurrence, and resistance to treatment.
• Understanding this interaction opens avenues for developing biomarkers based on host and viral factors for improved diagnosis and monitoring.
• It also suggests that effective therapies may need to target both viral oncogenes and host cellular mechanisms.